The Indian Pharmacopoeia Commission (IPC) Ghaziabad has added 10 new impurities standard. Now a total of 117 impurities and 537 Indian Pharmacopeia Reference Standards (IPRS) are available at IPC for stakeholders.
The move is to strengthen its availability of impurity standards and reference substances. The new list of impurity standards covered Carvedilol Impurity A, 3 Impurities of Quiniodochlor, Diazepam Impurity A, Alprostadil Impurity K, Butylparaben Impurity E and Tramadol Impurity A, Impurity of Carbamazepine (10,11 –Dihydrocarbamazepine) Oxacillin Impurity A, said Dr. PL. Sahu, Principal Scientific Officer, Head, R&D, Indian Pharmacopoeia Commission
Impurity standards are very essential for related substance analysis. Further, it is also important for ensuring the product quality, he added.
Impurity standards are used to perform the system suitability, qualitative and quantitative parameters for compliance to Indian Pharmacopoeia monograph.
The Commission has created a set of standards for drugs in the country. Its basic function is to update regularly the standards of drugs commonly required for treatment of diseases prevailing in this region. It publishes official documents for improving quality of medicines by adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP). It further promotes rational use of generic medicines by publishing National Formulary of India, said Dr Sahu.